Company · CIK 1637890
Celyad Oncology SA
| CIK | 1637890 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | C9 |
| Business address | Belgium |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2016-04-08 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-248464 | 2020-08-28 | 2021-01-07 | 4 | |
| 333-220285 | 2017-08-31 | 2019-09-12 | 6 | |
| 333-204251 | 2015-05-18 | 2015-06-19 | 5 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-01-07 | 424B5Shelf takedown | 333-248464 | 0001193125-21-003709 |
| 2020-09-11 | 424B5Shelf takedown | 333-248464 | 0001193125-20-244247 |
| 2020-09-04 | EFFECTDeclared effective | 333-248464 | 9999999995-20-002377 |
| 2020-08-28 | F-3Shelf registered | 333-248464 | 0001193125-20-234651 |
| 2019-09-12 | 424B5Shelf takedown | 333-220285 | 0001193125-19-244000 |
| 2019-09-10 | 424B5Shelf takedown | 333-220285 | 0001193125-19-241994 |
| 2018-05-18 | 424B5Shelf takedown | 333-220285 | 0001193125-18-168096 |
| 2018-05-16 | 424B5Shelf takedown | 333-220285 | 0001193125-18-164399 |
| 2017-10-06 | EFFECTDeclared effective | 333-220285 | 9999999995-17-002616 |
| 2017-08-31 | F-3Shelf registered | 333-220285 | 0001193125-17-274378 |
| 2015-06-19 | 424B4Final prospectus | 333-204251 | 0001193125-15-228500 |
| 2015-06-18 | EFFECTDeclared effective | 333-204724 | 9999999995-15-001673 |
| 2015-06-18 | EFFECTDeclared effective | 333-204251 | 9999999995-15-001668 |
| 2015-06-15 | F-1/AAmendment | 333-204251 | 0001193125-15-222438 |
| 2015-05-29 | F-1/AAmendment | 333-204251 | 0001193125-15-206869 |
| 2015-05-18 | F-1Registration filed | 333-204251 | 0001193125-15-191674 |
| 2015-03-31 | DRSDraft made public | 377-00969 | 0000950123-15-004195 |